IBDEI0PJ ; ; 01-FEB-2022
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,11479,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,11479,1,3,0)
;;=3^Left Ventricular Failure
;;^UTILITY(U,$J,358.3,11479,1,4,0)
;;=4^I50.1
;;^UTILITY(U,$J,358.3,11479,2)
;;=^5007238
;;^UTILITY(U,$J,358.3,11480,0)
;;=E21.3^^46^556^17
;;^UTILITY(U,$J,358.3,11480,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,11480,1,3,0)
;;=3^Hyperparathyroidism,Unspec
;;^UTILITY(U,$J,358.3,11480,1,4,0)
;;=4^E21.3
;;^UTILITY(U,$J,358.3,11480,2)
;;=^331438
;;^UTILITY(U,$J,358.3,11481,0)
;;=E78.5^^46^556^16
;;^UTILITY(U,$J,358.3,11481,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,11481,1,3,0)
;;=3^Hyperlipidemia,Unspec
;;^UTILITY(U,$J,358.3,11481,1,4,0)
;;=4^E78.5
;;^UTILITY(U,$J,358.3,11481,2)
;;=^5002969
;;^UTILITY(U,$J,358.3,11482,0)
;;=M10.30^^46^556^11
;;^UTILITY(U,$J,358.3,11482,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,11482,1,3,0)
;;=3^Gout d/t Renal Impairment,Unspec Site
;;^UTILITY(U,$J,358.3,11482,1,4,0)
;;=4^M10.30
;;^UTILITY(U,$J,358.3,11482,2)
;;=^5010356
;;^UTILITY(U,$J,358.3,11483,0)
;;=E66.9^^46^556^33
;;^UTILITY(U,$J,358.3,11483,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,11483,1,3,0)
;;=3^Obesity,Unspec
;;^UTILITY(U,$J,358.3,11483,1,4,0)
;;=4^E66.9
;;^UTILITY(U,$J,358.3,11483,2)
;;=^5002832
;;^UTILITY(U,$J,358.3,11484,0)
;;=E66.01^^46^556^32
;;^UTILITY(U,$J,358.3,11484,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,11484,1,3,0)
;;=3^Obesity,Morbid,d/t Excess Calories
;;^UTILITY(U,$J,358.3,11484,1,4,0)
;;=4^E66.01
;;^UTILITY(U,$J,358.3,11484,2)
;;=^5002826
;;^UTILITY(U,$J,358.3,11485,0)
;;=D50.9^^46^556^2
;;^UTILITY(U,$J,358.3,11485,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,11485,1,3,0)
;;=3^Anemia,Iron Deficiency,Unspec
;;^UTILITY(U,$J,358.3,11485,1,4,0)
;;=4^D50.9
;;^UTILITY(U,$J,358.3,11485,2)
;;=^5002283
;;^UTILITY(U,$J,358.3,11486,0)
;;=D63.1^^46^556^1
;;^UTILITY(U,$J,358.3,11486,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,11486,1,3,0)
;;=3^Anemia in Chronic Kidney Disease
;;^UTILITY(U,$J,358.3,11486,1,4,0)
;;=4^D63.1
;;^UTILITY(U,$J,358.3,11486,2)
;;=^332908
;;^UTILITY(U,$J,358.3,11487,0)
;;=G60.9^^46^556^31
;;^UTILITY(U,$J,358.3,11487,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,11487,1,3,0)
;;=3^Neuropathy,Hereditary/Idiopathic,Unspec
;;^UTILITY(U,$J,358.3,11487,1,4,0)
;;=4^G60.9
;;^UTILITY(U,$J,358.3,11487,2)
;;=^5004071
;;^UTILITY(U,$J,358.3,11488,0)
;;=I73.9^^46^556^34
;;^UTILITY(U,$J,358.3,11488,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,11488,1,3,0)
;;=3^PVD,Unspec
;;^UTILITY(U,$J,358.3,11488,1,4,0)
;;=4^I73.9
;;^UTILITY(U,$J,358.3,11488,2)
;;=^184182
;;^UTILITY(U,$J,358.3,11489,0)
;;=N04.9^^46^556^30
;;^UTILITY(U,$J,358.3,11489,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,11489,1,3,0)
;;=3^Nephrotic Syndrome w/ Unspec Morphologic Changes
;;^UTILITY(U,$J,358.3,11489,1,4,0)
;;=4^N04.9
;;^UTILITY(U,$J,358.3,11489,2)
;;=^5015540
;;^UTILITY(U,$J,358.3,11490,0)
;;=N25.0^^46^556^35
;;^UTILITY(U,$J,358.3,11490,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,11490,1,3,0)
;;=3^Renal Osteodystrophy
;;^UTILITY(U,$J,358.3,11490,1,4,0)
;;=4^N25.0
;;^UTILITY(U,$J,358.3,11490,2)
;;=^104747
;;^UTILITY(U,$J,358.3,11491,0)
;;=T80.211A^^46^556^3
;;^UTILITY(U,$J,358.3,11491,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,11491,1,3,0)
;;=3^Bloodstream Infection d/t Central Venous Catheter,Init Encntr
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI0PJ 3762 printed Apr 09, 2024@21:12:36 Page 2
IBDEI0PJ ; ; 01-FEB-2022
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,11479,1,0)
+2 ;;=^358.31IA^4^2
+3 ;;^UTILITY(U,$J,358.3,11479,1,3,0)
+4 ;;=3^Left Ventricular Failure
+5 ;;^UTILITY(U,$J,358.3,11479,1,4,0)
+6 ;;=4^I50.1
+7 ;;^UTILITY(U,$J,358.3,11479,2)
+8 ;;=^5007238
+9 ;;^UTILITY(U,$J,358.3,11480,0)
+10 ;;=E21.3^^46^556^17
+11 ;;^UTILITY(U,$J,358.3,11480,1,0)
+12 ;;=^358.31IA^4^2
+13 ;;^UTILITY(U,$J,358.3,11480,1,3,0)
+14 ;;=3^Hyperparathyroidism,Unspec
+15 ;;^UTILITY(U,$J,358.3,11480,1,4,0)
+16 ;;=4^E21.3
+17 ;;^UTILITY(U,$J,358.3,11480,2)
+18 ;;=^331438
+19 ;;^UTILITY(U,$J,358.3,11481,0)
+20 ;;=E78.5^^46^556^16
+21 ;;^UTILITY(U,$J,358.3,11481,1,0)
+22 ;;=^358.31IA^4^2
+23 ;;^UTILITY(U,$J,358.3,11481,1,3,0)
+24 ;;=3^Hyperlipidemia,Unspec
+25 ;;^UTILITY(U,$J,358.3,11481,1,4,0)
+26 ;;=4^E78.5
+27 ;;^UTILITY(U,$J,358.3,11481,2)
+28 ;;=^5002969
+29 ;;^UTILITY(U,$J,358.3,11482,0)
+30 ;;=M10.30^^46^556^11
+31 ;;^UTILITY(U,$J,358.3,11482,1,0)
+32 ;;=^358.31IA^4^2
+33 ;;^UTILITY(U,$J,358.3,11482,1,3,0)
+34 ;;=3^Gout d/t Renal Impairment,Unspec Site
+35 ;;^UTILITY(U,$J,358.3,11482,1,4,0)
+36 ;;=4^M10.30
+37 ;;^UTILITY(U,$J,358.3,11482,2)
+38 ;;=^5010356
+39 ;;^UTILITY(U,$J,358.3,11483,0)
+40 ;;=E66.9^^46^556^33
+41 ;;^UTILITY(U,$J,358.3,11483,1,0)
+42 ;;=^358.31IA^4^2
+43 ;;^UTILITY(U,$J,358.3,11483,1,3,0)
+44 ;;=3^Obesity,Unspec
+45 ;;^UTILITY(U,$J,358.3,11483,1,4,0)
+46 ;;=4^E66.9
+47 ;;^UTILITY(U,$J,358.3,11483,2)
+48 ;;=^5002832
+49 ;;^UTILITY(U,$J,358.3,11484,0)
+50 ;;=E66.01^^46^556^32
+51 ;;^UTILITY(U,$J,358.3,11484,1,0)
+52 ;;=^358.31IA^4^2
+53 ;;^UTILITY(U,$J,358.3,11484,1,3,0)
+54 ;;=3^Obesity,Morbid,d/t Excess Calories
+55 ;;^UTILITY(U,$J,358.3,11484,1,4,0)
+56 ;;=4^E66.01
+57 ;;^UTILITY(U,$J,358.3,11484,2)
+58 ;;=^5002826
+59 ;;^UTILITY(U,$J,358.3,11485,0)
+60 ;;=D50.9^^46^556^2
+61 ;;^UTILITY(U,$J,358.3,11485,1,0)
+62 ;;=^358.31IA^4^2
+63 ;;^UTILITY(U,$J,358.3,11485,1,3,0)
+64 ;;=3^Anemia,Iron Deficiency,Unspec
+65 ;;^UTILITY(U,$J,358.3,11485,1,4,0)
+66 ;;=4^D50.9
+67 ;;^UTILITY(U,$J,358.3,11485,2)
+68 ;;=^5002283
+69 ;;^UTILITY(U,$J,358.3,11486,0)
+70 ;;=D63.1^^46^556^1
+71 ;;^UTILITY(U,$J,358.3,11486,1,0)
+72 ;;=^358.31IA^4^2
+73 ;;^UTILITY(U,$J,358.3,11486,1,3,0)
+74 ;;=3^Anemia in Chronic Kidney Disease
+75 ;;^UTILITY(U,$J,358.3,11486,1,4,0)
+76 ;;=4^D63.1
+77 ;;^UTILITY(U,$J,358.3,11486,2)
+78 ;;=^332908
+79 ;;^UTILITY(U,$J,358.3,11487,0)
+80 ;;=G60.9^^46^556^31
+81 ;;^UTILITY(U,$J,358.3,11487,1,0)
+82 ;;=^358.31IA^4^2
+83 ;;^UTILITY(U,$J,358.3,11487,1,3,0)
+84 ;;=3^Neuropathy,Hereditary/Idiopathic,Unspec
+85 ;;^UTILITY(U,$J,358.3,11487,1,4,0)
+86 ;;=4^G60.9
+87 ;;^UTILITY(U,$J,358.3,11487,2)
+88 ;;=^5004071
+89 ;;^UTILITY(U,$J,358.3,11488,0)
+90 ;;=I73.9^^46^556^34
+91 ;;^UTILITY(U,$J,358.3,11488,1,0)
+92 ;;=^358.31IA^4^2
+93 ;;^UTILITY(U,$J,358.3,11488,1,3,0)
+94 ;;=3^PVD,Unspec
+95 ;;^UTILITY(U,$J,358.3,11488,1,4,0)
+96 ;;=4^I73.9
+97 ;;^UTILITY(U,$J,358.3,11488,2)
+98 ;;=^184182
+99 ;;^UTILITY(U,$J,358.3,11489,0)
+100 ;;=N04.9^^46^556^30
+101 ;;^UTILITY(U,$J,358.3,11489,1,0)
+102 ;;=^358.31IA^4^2
+103 ;;^UTILITY(U,$J,358.3,11489,1,3,0)
+104 ;;=3^Nephrotic Syndrome w/ Unspec Morphologic Changes
+105 ;;^UTILITY(U,$J,358.3,11489,1,4,0)
+106 ;;=4^N04.9
+107 ;;^UTILITY(U,$J,358.3,11489,2)
+108 ;;=^5015540
+109 ;;^UTILITY(U,$J,358.3,11490,0)
+110 ;;=N25.0^^46^556^35
+111 ;;^UTILITY(U,$J,358.3,11490,1,0)
+112 ;;=^358.31IA^4^2
+113 ;;^UTILITY(U,$J,358.3,11490,1,3,0)
+114 ;;=3^Renal Osteodystrophy
+115 ;;^UTILITY(U,$J,358.3,11490,1,4,0)
+116 ;;=4^N25.0
+117 ;;^UTILITY(U,$J,358.3,11490,2)
+118 ;;=^104747
+119 ;;^UTILITY(U,$J,358.3,11491,0)
+120 ;;=T80.211A^^46^556^3
+121 ;;^UTILITY(U,$J,358.3,11491,1,0)
+122 ;;=^358.31IA^4^2
+123 ;;^UTILITY(U,$J,358.3,11491,1,3,0)
+124 ;;=3^Bloodstream Infection d/t Central Venous Catheter,Init Encntr
